Upcoming Events

American Society of Nephrology Kidney Week 2019

November 5 - 10, 2019 | Washington, DC
Oral Presentations
  • Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the J-DOPPS (Oral # TH-OR030)
  • International peritoneal dialysis training practices and the risk of peritonitis (Oral # FR-OR109)
  • Peritoneal dialysis modality and interference in daily life: Results from the PDOPPS (Oral # FR-OR108)
  • Hyperkalemia excursions and mortality in hemodialysis patients: Results from the DOPPS (Oral # SA-OR067)
  • Urban segregation and hospitalization outcomes in patients on hemodialysis (Oral # SA-OR060)
Poster Presentations
  • Pruritus and mortality in hemodialysis patients: Results from the international DOPPS (Poster # TH-PO243)
  • Pruritus and patient reported outcomes (PROs): Associations between the Skindex-10 and PROs in hemodialysis patients (Poster # TH-PO244)
  • PTH levels prior to initiating hemodialysis: Associations with prescription of PTH-lowering therapies and risk of uncontrolled PTH during the first (Poster # FR-PO128)
  • Etelcalcetide utilization and CKD-MBD marker responses in US hemodialysis patients (Poster # FR-PO135)
  • Dialysate citrate and mortality in the Dialysis Outcomes and Practice Patterns Study (Poster # FR-PO484)
  • International variation in outcomes after peritoneal dialysis-related peritonitis (Poster # FR-PO534)
  • Patterns of care for lipid management in CKD Stage 3-5 patients: Results from the CKDopps (Poster # SA-PO883)

Past Events

American Society of Nephrology Kidney Week 2019

November 5 - 10, 2019 | Washington, DC
Oral Presentations
  • Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the J-DOPPS (Oral # TH-OR030)
  • International peritoneal dialysis training practices and the risk of peritonitis (Oral # FR-OR109)
  • Peritoneal dialysis modality and interference in daily life: Results from the PDOPPS (Oral # FR-OR108)
  • Hyperkalemia excursions and mortality in hemodialysis patients: Results from the DOPPS (Oral # SA-OR067)
  • Urban segregation and hospitalization outcomes in patients on hemodialysis (Oral # SA-OR060)
Poster Presentations
  • Pruritus and mortality in hemodialysis patients: Results from the international DOPPS (Poster # TH-PO243)
  • Pruritus and patient reported outcomes (PROs): Associations between the Skindex-10 and PROs in hemodialysis patients (Poster # TH-PO244)
  • PTH levels prior to initiating hemodialysis: Associations with prescription of PTH-lowering therapies and risk of uncontrolled PTH during the first (Poster # FR-PO128)
  • Etelcalcetide utilization and CKD-MBD marker responses in US hemodialysis patients (Poster # FR-PO135)
  • Dialysate citrate and mortality in the Dialysis Outcomes and Practice Patterns Study (Poster # FR-PO484)
  • International variation in outcomes after peritoneal dialysis-related peritonitis (Poster # FR-PO534)
  • Patterns of care for lipid management in CKD Stage 3-5 patients: Results from the CKDopps (Poster # SA-PO883)

French Society of Dialysis and Transplantation (SFNDT)

October 1 - 4, 2019 | Nancy, France
Topic and Speaker:
The DOPPS Odyssey: Reducing unwarranted practice variation really does improve dialysis patient outcomes! – Bruce Robinson
Wednesday, October 2, 2019: 10:00 AM - 10:45 AM

48th EDTNA/ERCA International Conference

September 14 - 17, 2019 | Prague, Czech Republic
Symposium: Update from the DOPPS Program: Centering care around patients
Sunday, September 15, 2019: 11:00 AM - 12:30 PM
Hall A2

Topics and Speakers:
  • DOPPS: Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in haemodialysis patients - Jennie King
  • PDOPPS: Perceptions about the dialysis modality decision process among peritoneal dialysis and in-centre haemodialysis patients - Anna Marti i Monros
  • CKDopps: Coping with kidney disease - qualitative findings from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study - Michel Roden
  • Patient perspectives on the choice of dialysis modality: Results from the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) study -  Marisa Pegoraro

9th Asia Pacific Chapter Meeting of the ISPD

September 5 - 7, 2019 | Nagoya, Japan
Symposium:
Friday, September 6, 2019: 2:00 PM - 3:40 PM
Nagoya Congress Center

Topics and Speakers:
  • PDOPPS: Current status of worldwide PDOPPS – Jeffrey Perl 
  • Treatment and Prevention of Peritoneal Dialysis Related Infections in PDOPPS – Neil Boudville
  • Novel Insights in PD First Policy from PDOPPS – Talerngsak Kanjanabuch
  • Expectation and Influence of PDOPPS to Japan – Kawanishi H

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 13-16, 2019 | Budapest, Hungary
Poster Presentations
Friday, June 14
  • Kt/V Achievement and Mortality in Hemodialysis Patients in the Gulf Cooperation Council (GCC) Countries: Results from DOPPS (2012-2018) (Poster #FP530)
Saturday, June 15
  • Impact of long term serum phosphorus control on cardiovascular mortality using a 6-month area under the curve approach in the DOPPS (Poster #SP603)
  • Hemoglobin, Patient-Reported Physical Activity, and Risk of Death and CKD Progression in Stage 3-5 CKD Patients: Results from CKDopps (Poster #SP329)

ISN World Congress of Nephrology 2019

April 12 - 15, 2019 | Melbourne, Australia
Symposium: Listening to patients to improve outcomes for persons nearing kidney failure or on dialysis
Friday, April 12, 2019: 2:00 PM - 4:00 PM
Session Chairs: Simon Davies and Allison Tong
Topics and Speakers:
  • Shared decision making regarding treatment options for kidney failure – Roberto Pecoits-Filho
  • Advantages and disadvantages of peritoneal dialysis: what do patients tell us? – Angela Yee Moon Wang
  • Expanding options for frail persons with kidney failure: assisted home dialysis, dialysis avoidance, and dialysis withdrawal – Norio Hanafusa
  • Empowering dialysis patients: Understanding and improving patient-provider connections – Lalita Subramanian

American Society of Nephrology Kidney Week 2018

October 23 - 28, 2018 | San Diego, CA | Booth #2236

Clinical Session with DOPPS Program Talks
Transitioning Patients to Dialysis Care: Caring for Patients in a Vulnerable Time Period
Saturday, October 27, 2018
2:00 PM – 4:00 PM
Location: 6B

Moderators: Maria V. DeVita and Eric L. Wallace

Topics and Speakers:

  • "Be Prepared...": Offering Real Choice and Adequate Preparation for Patients Facing Kidney Failure (CKDopps) - Ziad Massy
  • Education During Transitions to ESRD - Matthew J. Oliver
  • "Steady as She Goes...": Limiting Complications and Improving Survival in the Early Dialysis Period (DOPPS) - Bruce M. Robinson
  • A Novel Transition Program in Action - Brendan T. Bowman

Oral Presentations

  • International Comparisons of Mortality Among Hemodialysis Patients in the DOPPS (#TH-OR092)

Poster Presentations

  • Associations of Anemia with Quality of Life in CKD Stage 3-5 Patients: Results from CKDopps in the US and Brazil (#TH-PO266)
  • Cinacalcet Prescription Across US Hemodialysis Facilities: Facility Variability and Predictors (#SA-PO666)
  • The impact of newly developed inflammation, characterized by rise in C-reactive protein, on anemia management practices in hemodialysis patients: A before-after design in the DOPPS (#TH-PO252)
  • Beta-2 Microglobulin Levels and All-Cause Mortality: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (#FR-PO825)
  • Estimating the Fraction of First-year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS (#FR-PO801)
  • Differing Attitudes towards peritoneal dialysis (PD) among PD and hemodialysis (HD) Medical Directors (#TH-PO372)
  • Regional Variation in Peritoneal Dialysis (PD) Time on Therapy (ToT): Results from The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (#TH-PO371)

47th EDTNA/ERCA International Conference

September 15 - 18, 2018 | Genoa, Italy | Booth #21

Symposium: Update from the DOPPS Program: Improving care, outcomes, and the patient experience
Sunday, September 16, 2018: 12:45 PM - 1:45 PM
Grecale Room

Topics and Speakers:

  • DOPPS: Key hemodialysis practice changes and their impact – Loreto Gesualdo
  • PDOPPS: New insights into optimal PD practice – Jen King
  • CKDopps: Opportunities to improve care now for patients with advanced CKD – Solène Laville
  • Empowering patients: Understanding and improving patient-provider connections – Marisa Pegoraro

Japanese Society for Dialysis Therapy (JSDT)

June 28 - July 1, 2018 | Kobe, Japan

DOPPS Symposium: Sunday, July 1 at 8:20 a.m.

Chairpersons: Masafumi Fukagawa and Masaomi Nangaku
Speakers:

  • Masaaki Inaba
  • Kousaku Nitta
  • Bruce Robinson
  • Junichi Hosino
  • Suguru Yamamoto
  • Tadao Akizawa

PDOPPS Symposium: Sunday, July 1 at 10:20 a.m.

Chairpersons: Hideki Kawanishi and Bruce Robinson
Speakers:

  • Bruce Robinson
  • Hideki Kawanishi
  • Yasuhiko Ito
  • Mizuya Fukasawa
  • Tadashi Tomo

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

May 24-27, 2018 | Copenhagen, Denmark | Booth #2.162

DOPPS Program Clinical Symposium
The sweet truth: Optimizing care in advanced CKD and dialysis with a focus on diabetic patients
Friday, May 25, 11:45 a.m. – 1:15 p.m., Room C1-M1-2

Chairpersons: Helmut Reichel and Bruce Robinson

Topics and Speakers:

  • DOPPS Program: The burden of diabetes in advanced CKD and dialysis - Bruce Robinson
  • PDOPPS: Variation in the PD prescription, glucose exposure, and outcomes - Mark Lambie
  • DOPPS: Hepatitis C in HD patients - prevalence trends over 20 years, outcomes, and use of newer treatments - Michel Jadoul
  • CKDopps: Diabetes treatment, control, and hypoglycemia in patients with advanced CKD - Benedicte Stengel
  • EURODOPPS: Outcomes according to different strategies of HbA1c use among diabetic HD patients - Ionut Nistor

Poster Presentations

Friday, May 25

  • Changes in practice patterns in Japan from before to after JSDT 2013 guidelines on hemodialysis prescriptions (Poster #FP638)
  • CKD progression in Germany (Poster #FP346)
  • International variation in MBD measurement, vitamin D prescription, and phosphate binder prescription patterns among patients with chronic kidney disease (Poster #FP386)
  • Patient-reported disadvantages of peritoneal dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #FP483)
  • Satisfaction, convenience, and difficulties in taking phosphate binders: Relationships with phosphate binder adherence in hemodialysis patients in the DOPPS (Poster #FP610)

Saturday, May 26

  • Association between dipeptidyl peptidase-4 inhibitor prescription and erythropoiesis stimulating agent hyporesponsiveness in hemodialysis patients with diabetes mellitus (Poster #SP345)
  • Indoxyl sulfate and mortality in hemodialysis patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS) (Poster #SP617)
  • Is low hemoglobin at hemodialysis initiation associated with first-year survival among patients treated to target levels soon after dialysis start? (Poster #SP340)
  • Remote management for peritoneal dialysis: Perspectives on effects on care (Poster #SP502)
  • The association of functional status with mortality and dialysis modality change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Poster #SP532)

American Society of Nephrology Kidney Week 2017

October 31 - November 5, 2017 | New Orleans, LA

Oral Presentations

  • Are RAASi underused in moderate to advanced CKD? Early findings from CKDopps
  • Contemporary anemia management in peritoneal dialysis patients: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)  
  • Low serum potassium is associated with indicators of under-nutrition and reduced residual kidney function: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

46th EDTNA/ERCA International Conference

September 9 -12, 2017 | Krakow, Poland

Symposium: The DOPPS Program Continues to Grow
Sunday, September 10, 2017: 12:45 PM - 1:45 PM
Theater Hall

Topics and Speakers:

  • Key hemodialysis practice changes and their impact – Andrzej Wiecek
  • PDOPPS: Identifying optimal practices in PD – Jen King
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis – Elodie Speyer
  • “Ask your patients and do something about it”: The patient perspective in DOPPS – Jeanette Wallin

European Renal Association / European Dialysis and Transplant Association (ERA-EDTA)

June 3-6, 2017 | Madrid, Spain

Symposium: Optimizing care in advanced CKD and the transition to dialysis: Insights from DOPPS Program

June 5, 2017 at 3:15 p.m. 

Session number S 37, Hall 10

Topics and Speakers:

  • The DOPPS Program: invitation to collaborators - Hugh Rayner
  • CKDopps: Improving outcomes in advanced CKD and the transition to dialysis - Helmut Reichel
  • DOPPS: Impact of clinical practices on early mortality among HD patients - Takeshi Hasegawa
  • PDOPPS: Predictors of early successful PD use - Martin Wilkie
  • Recent results from the EURODOPPS - Ayesha Sajjad

Free Communications

Sunday, June 4

  • Cinacalcet discontinuation and its predictors in hemodialysis patients: Results from 7 European countries (#SO034). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Regional variation in mineral and bone disorder (MBD) markers and treatment at dialysis start: Results from the DOPPS (#SO032). Session: CKD-MBD in dialysis (3:15 p.m.)
  • Dialysate calcium concentration <3.0mEq/L is not associated with improved outcomes in the Japan DOPPS (#SO061). Session: Epidemiology in dialysis – 2 (5:00-6:30 p.m.)

Monday, June 5

  • International differences in time from arteriovenous fistula (AVF) creation until becoming catheter-free among HD patients using a catheter at time of AVF creation: Results from the DOPPS (#MO047). Session: Vascular Access (3:15 p.m.)
  • Early Peritoneal Dialysis Attrition: Preliminary Results from The Peritoneal DOPPS (#MO061). Session: Peritoneal dialysis (5:00 p.m.)

Posters

Sunday, June 4, 9:30-10:45 a.m.

  • Associations of coping strategies with quality of life, depression and mortality among hemodialysis patients in the DOPPS (#SP623)
  • Hypokalemia in the Peritoneal Dialysis and Outcome Practice Patterns Study (PDOPPS): International variability and clinical predictors (#SP498)
  • International variation in PD catheter practices: Preliminary results from the Peritoneal DOPPS (#SP503)
  • Renin-angiotensin-aldosterone system inhibitors (RAASi) and clinical outcomes in hemodialysis patients: Results from the DOPPS (#SP551)
  • Treatments of mineral and bone disorder may be under-utilized in CKD patients (#SP369)

Monday, June 5, 9:30-10:45 a.m.

  • Prevalence of hyperkalemia in DOPPS: A real-world, international cohort of hemodialysis patients (#MP371)
  • Renin-angiotensin-aldosterone system inhibitor prescription patterns in hemodialysis patients: Results from the International DOPPS (#MP385)
  • Variation in Renin Angiotensin Aldosterone System Inhibitor (RAASi) prescription internationally and across CKD stages (#MP409)
  • Regional Differences in the Associations between Prescribed Dialysate Sodium Concentration and Interdialytic Weight Gain in the DOPPS: A Call for Quality Assurance? (#MP704)

American Society of Nephrology Kidney Week 2016

November 15-20, 2016 | Chicago, IL
  • International variation in dialysis discontinuation: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract #TH-PO1108)
  • Association between diuretic use and residual kidney function in peritoneal dialysis patients: International comparison from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) (Abstract #SA-PO1102)
  • Prevalence and dosing patterns of ESAs used in 9 European countries: DOPPS (Abstract #SA-PO1007)
  • Hyperkalemia and prescription of antihypertensive medications: Early findings from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #SA-PO796)
  • International variations in the frequency of the types of patient-physician contact for CKD patients: Early findings from CKDopps (Abstract #SA-PO927)
  • Geographical and seasonal patterns of blood pressure in hemodialysis patients: A EURODOPPS study (Abstract #TH-PO990)
  •  Higher phosphorus is associated with lower hemoglobin in CKD stages 3-5: Early results from the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) (Abstract #FR-PO789)
  •  Facility use of low dialysate temperature for prevention of intra-dialytic hypotension is associated with lower cardiovascular mortality in the DOPPS (Abstract #FR-PO938)

Theme picker